Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Highly Accessed Review

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Suzanne Dunne*, Bill Shannon, Colum Dunne and Walter Cullen

BMC Pharmacology and Toxicology 2013, 14:1  doi:10.1186/2050-6511-14-1


  • Last 30 days: 815 accesses
  • Last 365 days: 8471 accesses
  • All time: 10169 accesses

Cited by